Bank of Montreal
RCPI

Bank of Montreal’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Bank of Montreal’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-160
Closed -$2K – 4837
2014
Q2 		$2K Buy
+160
New +$2.78K ﹤0.01% 4561

Other funds holding RCPI

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

Bank of Montreal's RCPI Position: Q3 2014 in Review

Bank of Montreal sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2014, closing a stake of 160 shares — an estimated $2K sold.

Bank of Montreal first reported a position in RCPI in Q2 2014 and held it in 1 quarter. The position peaked at $2K in Q2 2014. 67 funds tracked by Wall St. Rank hold RCPI as of Q3 2014.

  • Bank of Montreal reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Bank of Montreal sold 160 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $2K.
  • Bank of Montreal first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Bank of Montreal's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $2K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Bank of Montreal's 13F filing for Q3 2014, filed 7 Nov 2014.